Comparison of safety profiles for dapagliflozin based on EMA and FDA safety issues: Challenges and future of post-marketing surveillance in Korea
- Suvin Park
- , Hee Jin Kim
- , Heehyun Won
- , Hui Eon Lee
- , Haerin Cho
- , Nam Kyong Choi
Research output: Contribution to journal › Article › peer-review
3
Scopus
citations